Home Ablynx agrees Merck cancer deal worth up to 1.7 billion euros
 

Keywords :   


Ablynx agrees Merck cancer deal worth up to 1.7 billion euros

2014-02-04 08:05:11| Biotech - Topix.net

Belgian biotech company Ablynx has signed a deal with Merck & Co worth up to 1.7 billion euros to develop ways of triggering the body to fight cancer by itself.

Tags: deal worth cancer euros

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »